Correction to: Journal of Neurology https://doi.org/10.1007/s00415-023-11700-7
The original version of this article unfortunately contained a mistake. The several values in Table 1 have shifted up from the correct row. Category of N Previous treatments, N%” has 4 sub-entries, with which the values should be aligned. And the same is for “Type of Last Previous Treatments, N%”, which has 7 sub-entries with which the values should be aligned.
The corrected Table 1 is given in the following page.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zanetta, C., Rocca, M.A., Meani, A. et al. Correction to: Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing–remitting multiple sclerosis patients: a monocentric longitudinal observational study. J Neurol 270, 3565–3566 (2023). https://doi.org/10.1007/s00415-023-11772-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-023-11772-5